Bosutinib for Chronic Myeloid Leukemia.

about

Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

P2860

Q38707841-181D6F39-77C4-4D65-A12F-B7A7D9EB56A0

P2860

Bosutinib for Chronic Myeloid Leukemia.

Item

http://www.wikidata.org/entity/Q38835127

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bosutinib for Chronic Myeloid Leukemia.

@en

type

Item

label

Bosutinib for Chronic Myeloid Leukemia.

@en

prefLabel

Bosutinib for Chronic Myeloid Leukemia.

@en

P1476

Bosutinib for Chronic Myeloid Leukemia.

@en

P2093

Gianni Binotto

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).

Pharmacokinetic-pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia.

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.

The molecular biology of chronic myeloid leukemia.

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.

In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.

P304

35-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40487-015-0010-Y

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Breccia

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281304076

http://www.w3.org/2001/XMLSchema#string

P698

27182477

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

4837934

http://www.w3.org/2001/XMLSchema#string

Bosutinib for Chronic Myeloid Leukemia.

about

P2860

P2860

Bosutinib for Chronic Myeloid Leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932